NCT07105189

Brief Summary

The goal of this feasibility study is to explore the use of wireless continuous vital sign monitoring in an orthopaedic setting among orthopaedic nurses and patients undergoing adult spinal deformity surgery. In addition to the standard care National Early Warning Score the participants in this study will be monitored by CPC12S a wearable sensor that is worn on the chest using electrodes measuring electrocardiography single lead (ECG), Heart rate, respiratory rate, SpO2, blood pressure and temperature. Main hypotheses: The use of wireless continuous vital sign monitoring in daily clinical practice for patients undergoing ASD surgery is feasible in terms of increased acceptability among orthopeadic surgical nurses measured over 12 months with a response rate of at least 80% with an average score of ≥5 at the last measurement in each of the four dimensions of the USE questionnaire: Usefulness, ease of use, ease of learning and satisfaction. The following parameters will be evaluated: Primary outcome:

  1. 1.The feasibility in terms of acceptability of the concept of wCVSM among orthopedic surgical ward nurses.
  2. 2.The feasibility in terms of acceptability of the concept of wCVSM in patients undergoing ASD surgery.
  3. 3.The technical fidelity of wCVSM, assessed by data collected of vital signs, display of alerts to staff nurses and response to the alerts.
  4. 4.The frequency of vital sign deviations in patients after ASD surgery using wCVSM compared to NEWS2.
  5. 5.Clinical outcomes of patients undergoing ASD surgery including surgical complications, reinterventions, ICU admissions, unplanned ward transfer, and admissions to another department.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
4mo left

Started Dec 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress57%
Dec 2025Aug 2026

First Submitted

Initial submission to the registry

January 10, 2025

Completed
7 months until next milestone

First Posted

Study publicly available on registry

August 5, 2025

Completed
4 months until next milestone

Study Start

First participant enrolled

December 10, 2025

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2026

Last Updated

January 8, 2026

Status Verified

January 1, 2026

Enrollment Period

8 months

First QC Date

January 10, 2025

Last Update Submit

January 6, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Assessment of acceptability of the concept of wCVSM among orthopedic surgical ward nurses.

    USE questionnaires will be distributed to the nurses taking care of patients undergoing ASD surgery.

    At 1, 6 and 12 months after post-implementation

Secondary Outcomes (4)

  • Assessment of acceptability of the concept of wCVSM in patients undergoing ASD surgery.

    up to 7 days

  • Tecnical fidelity of the functioning of the continuous monitoring system

    Up to 7 days

  • Frequency of deviations in vital signs in patients after ASD surgery using wCVSM compared to NEWS2

    Up to 7 days

  • Assessment of clinical outcomes after ASD surgery

    Up to 30 days

Study Arms (1)

Wireless continuous vital sign monitoring in patients undergoing adult spinal deformity surgery

EXPERIMENTAL

Participants in this arm will receive a wearable wireless continuous vital sign monitoring system (CPC12S), applied after spinal deformity surgery and worn during the initial postoperative period (typically 3-5 days). The device transmits data wirelessly to a mobile application accessed by nursing staff.

Device: Wireless monitoring

Interventions

Patients included in the study will be continuous monitored by CPC12S is a wearable sensor that is worn on the chest using electrodes measuring electrocardiography single lead (ECG), Heart rate, respiratory rate, SpO2, blood pressure and temperature. The system calculates the heart rate by analysing R-peaks of QRS-complexes in the raw ECG data. Respiratory rate is recorded using impedance pneumography. SpO2 is determined by analysing the photoplethysmogram (PPG) wave. Blood pressure is derived by calculating the pulse transit time (PTT) using R-peaks from the QRS complexes, peaks in the photoplethysmogram (PPG) pulse waves, and timing of the second heart-tone corresponding to the dicrotic notch, measured by a stethoscope in the device. Temperature is measured by a thermistor placed in the axilla. Vital signs are updated every 20 seconds and measurements are transmitted via Bluetooth to an Android cell phone that is uploading the data via WIFI to a secured server.

Wireless continuous vital sign monitoring in patients undergoing adult spinal deformity surgery

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Included are adult patients (\>=18 years) scheduled for ASD surgery with estimated a \>3 day expected post-operative stay. ASD-surgery is defined as a posterior instrumented fusion of at least five spinal levels including instrumentation to the pelvis, caused by a degenerative condition of the spine.
  • Registered nurses and nurses' assistants employed at the orthopedic ward during the study period will be included if they have experience working with wCVSM during the study period. The study includes both sexes, variation of level of education and years of work experience. Included nurses and nurses' assistants should be proficient in the Danish language.

You may not qualify if:

  • Patients who are not proficient in the Danish language will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Bone and Joint surgery, University hospital, Rigshospitalet, Copenhagen

Copenhagen, 2100, Denmark

RECRUITING

Central Study Contacts

Camilla Hedegaard Larsen

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical nurse specialist and Ph.d-student

Study Record Dates

First Submitted

January 10, 2025

First Posted

August 5, 2025

Study Start

December 10, 2025

Primary Completion (Estimated)

July 30, 2026

Study Completion (Estimated)

August 30, 2026

Last Updated

January 8, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
Following publication of the manuscript and for five years afterwards
Access Criteria
Following publication of the manuscript, deidentified individual participant data will be available upon reasonable request. The project team will review each request on a case-by-case basis for a period of five years.

Locations